Our continuing vision for the Molecular Imaging Program at Stanford (MIPS) has been to bring molecular imaging technologies to basic science cancer researchers – to create an environment in which non-invasive imaging technologies that permit longitudinal studies of tumor initiation, progression, metastasis and response to therapy would be adopted by basic scientists studying cancer. Within the MIPS program, we continue to develop animal models of cancer in which molecular imaging adds new dimensions to experimental design and allows investigators to acquire time-dependent data that could not be obtained in any other way. The MIPS program is supported by numerous funding sources, including the National Institutes of Health, multiple foundations, and strong industry partnerships. Since the inception of MIPS (2003), we have followed a clearly defined roadmap toward translating our work into clinical use to benefit patients.

News & Events

Recent News

Stanford Researchers Develop Magnetic Wire that Increases Detection of Circulating Tumor Cells

July 16, 2018

MIPS Research Featured on the Cover of Pancreas

July 11, 2018

Israt Alam, PhD, Received 2nd Place Radiopharmaceutical Sciences Young Investigator Award at 2018 SNMMI

June 27, 2018

Thomas Haywood, PhD, Received 2nd Place Brain Imaging Council’s Young Investigator Award at 2018 SNMMI

June 27, 2018

Aaron Mayer Received 2018 SNMMI Alavi–Mandell Award

June 27, 2018

Mirwais Wardak, PhD, Received 2nd Place Cardiovascular Council Young Investigator Award at 2018 SNMMI

June 27, 2018

Dr. Gambhir Received 2018 Benedict Cassen Prize for Research in Molecular Imaging

June 25, 2018

Collaborative Paper from Molecular Imaging Instrumentation Lab Received Alavi-Mandell Award

June 22, 2018

Aisling Chaney Received 2018 ERF-SNMMI Post-Doctoral Molecular Imaging Scholar Grant

June 7, 2018

Researchers in Molecular Imaging Instrumentation Lab Receive AAPM Sylvia & Moses Greenfield Paper Award

May 23, 2018